Brokerages Set Option Care Health, Inc. (NASDAQ:OPCH) Price Target at $30.08

Option Care Health, Inc. (NASDAQ:OPCH) has been given a consensus rating of “Moderate Buy” by the fourteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have given a hold rating and eight have given a buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $30.0769.

OPCH has been the subject of several analyst reports. Barrington Research decreased their target price on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Truist Financial set a $30.00 target price on Option Care Health in a research note on Friday, May 1st. Stephens reiterated an “equal weight” rating and set a $24.00 target price (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $26.00 price target on shares of Option Care Health in a report on Friday, May 1st. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research report on Monday, May 4th.

Insider Activity

In other news, Director Timothy P. Sullivan purchased 24,154 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were purchased at an average price of $20.69 per share, with a total value of $499,746.26. Following the purchase, the director directly owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. This represents a 49.06% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO John Charles Rademacher purchased 12,500 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders bought 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is currently owned by company insiders.

Institutional Trading of Option Care Health

Several large investors have recently modified their holdings of the business. V Square Quantitative Management LLC acquired a new position in shares of Option Care Health in the fourth quarter worth about $25,000. Advisory Services Network LLC purchased a new position in Option Care Health in the third quarter valued at about $35,000. McIlrath & Eck LLC acquired a new stake in Option Care Health during the 2nd quarter valued at approximately $37,000. Caitong International Asset Management Co. Ltd acquired a new stake in Option Care Health during the 3rd quarter valued at approximately $38,000. Finally, Quarry LP increased its holdings in Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after purchasing an additional 1,292 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Performance

Shares of OPCH stock opened at $21.66 on Wednesday. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. The company has a market cap of $3.40 billion, a PE ratio of 16.79, a P/E/G ratio of 1.20 and a beta of 0.65. The company’s fifty day simple moving average is $21.32 and its 200-day simple moving average is $27.09. Option Care Health has a 52 week low of $18.01 and a 52 week high of $36.80.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. During the same period in the prior year, the company earned $0.40 EPS. The firm’s revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, equities research analysts anticipate that Option Care Health will post 1.64 EPS for the current year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.